JPRN-UMIN000035812已完成2 期
Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer - Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1: Cases with serious complications Interstitial pneumonia Serious heart disease diabetes which is difficult to control Serious infectious diseases 2: Cases with other active organs and overlapping cancers 3: Patients with a history of severe hypersensitivity 4: Case in which flucytosine is being administered 5) Cases with a history of alcohol hypersensitivity
研究者
相似试验
暂停
不适用
Phase I/II Trial of S-1 plus paclitaxel combination chemotherapy in elderly patients with non-small lung canceron-small cell lung cancerJPRN-UMIN000003782Kyoto prefectural University of Medicine45
已完成
2 期
A Phase II Study of Paclitaxel+S-1 for previously treated Non-Small Cell Lung CancerAdvanced or relapsed Non-Small Cell Lung CancerJPRN-UMIN000003719Osaka Medical Center for Cancer and Cardiovascular Diseases50
已完成
不适用
A Phase I/II study of nab-Paclitaxel plus S-1 therapy in previously treated patients with refractory advanced non-small-cell lung cancerJPRN-UMIN000012966Depatment of Thoracic Oncology Osaka Medical Center for Cancer and Cardiovascular Diseases45
尚未招募
不适用
Phase II study of nab-paclitaxel combined with S-1 in patients with early breast cancer:A multicenter clinical trialearly breast cancerJPRN-UMIN000027216The University of Tokushima Graduate School80
已完成
2 期
Phase II study of Nab-paclitaxel plus S-1 followed by FEC as neoadjuvant chemotherapy for the operable breast cancerbreast cancerJPRN-UMIN000017177Kitasato University Kitasato Institute Hospital28